•  IVIG, combined with moderate-dose of corticosteroids, might improve patient outcomes.
•  The use of corticosteroids might accelerate recovery from COVID-19.
•  No controlled clinical trials exist on the use of corticosteroids for COVID-19.
•  IL6 correlates with severity, criticality, viral load, and prognosis of COVID-19.
•  Tocilizumab, an anti-IL6, can confer benefit in patients with COVID-19 and high IL6.